FindMyKOL
Clinical trialNCT01105247CompletedPhase 1/PHASE2Interventional

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

SponsorPharmacyclics LLC.Enrollment133B-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to establish the safety and efficacy of orally administered PCI-32765 in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University School of Medicine

    Stanford, California, United States

  • New York Presbyterian Hosptial Cornell Med Center

    New York, New York, United States

  • the Ohio State University

    Columbus, Ohio, United States

  • Willamette Valley Cancer Institute and Research Center

    Springfield, Oregon, United States

  • Sarah Cannon

    Nashville, Tennessee, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

  • Texas Oncology - Tyler

    Tyler, Texas, United States

  • University of Vermont and Fletcher Allen Health Care

    Burlington, Vermont, United States

  • Northwest Cancer Specialists, P.C.

    Vancouver, Washington, United States

  • Yakima Valley Memorial

    Yakima, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PCI-32765
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2010
Primary completion
31 Dec 2012
Completion
28 Feb 2013
Last update posted
31 Mar 2014
Registered enrollment
133
Registry id
NCT01105247
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.